GSTM1 and GSTT1 polymorphisms and the risk of prostate cancer in a Caribbean population of African descent

Urology. 2007 Jun;69(6):1165-9. doi: 10.1016/j.urology.2007.02.039.

Abstract

Objectives: To investigate whether the glutathione S-transferase polymorphisms GSTM1 and/or GSTT1 contribute to prostate cancer risk in a Caribbean population of African descent in Guadeloupe.

Methods: We performed a hospital-based case-control study with 134 prostate cancer patients and 134 cancer-free, age-matched control subjects. Epidemiologic data were collected using a standard questionnaire. Logistic regression was used to estimate odds ratios (ORs) and compute confidence intervals (CIs). Genotypes were determined by multiplex polymerase chain reaction.

Results: The frequency of the GSTM1-positive genotype was 81% in patients and 73% in control subjects, with an adjusted OR of 1.4 (95% CI 0.7 to 2.5). The frequency of the GSTT1-positive genotype was 78% in patients and 63% in control subjects, with an adjusted OR of 2.6 (95% CI 1.4 to 4.9).

Conclusions: A functional GSTT1 polymorphism may be associated with prostate cancer susceptibility in a Caribbean population of African descent.

Publication types

  • Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Black or African American
  • Caribbean Region / epidemiology
  • Caribbean Region / ethnology
  • Case-Control Studies
  • Glutathione Transferase / genetics*
  • Humans
  • Male
  • Middle Aged
  • Polymerase Chain Reaction
  • Polymorphism, Genetic
  • Prostatic Neoplasms / epidemiology
  • Prostatic Neoplasms / genetics*
  • Risk Factors

Substances

  • glutathione S-transferase T1
  • Glutathione Transferase
  • glutathione S-transferase M1